Mangalam Drugs And Organics Limited — Board Meeting, 17-05-2025: Outcome of Board Meeting

Mangalam Drugs and Organics has announced a board meeting approving the consolidated financial results for the quarter and financial year ended March 31, 2025, backed by a clean audit report. The company appointed Ragini Chokshi & Co. as Secretarial Auditor for FY 2025-26, signaling a boost to its governance framework. No dividend or fundraising plans were shared. Overall, the focus remains on solid financial health and compliance, keeping the business on a steady path for investors.